English 中文
English
 

Min Cui

Min Cui, Ph.D.
Managing Director

Dr. Min Cui is the Founding Partner and Managing Director of Decheng Capital. Prior to founding Decheng Capital in 2011, Dr. Cui was an Investment Partner at Bay City Capital, a leading international life science venture capital firm, and focused on evaluating investment opportunities as well as its initiatives in China. Dr. Cui was previously Director of Strategic Investment for the Southern Research Institute, an organization that discovered and developed six anti-cancer drugs that approved by the US Food and Drug Administration. Prior to that, Dr. Cui co-founded Pan Pacific Pharmaceuticals and Hucon Biopharmaceuticals. He served as the Chief Scientific Officer and Executive Vice President of Pan Pacific Pharmaceuticals from 1998 to 2002 and Chief Executive Officer and President of Hucon Biopharmaceuticals from 2003 to 2005, respectively. In these positions, he led efforts in discovery and development of several key technologies in the fields of oncology, cardiology, infectious and inflammatory diseases. Dr. Cui is a member of the board of directors of GenapSys, GeneWeave Biosciences (acquired by Roche for $425M), Ketai Medical, Shenzhen GeneMDx Biotechnology, Accuragen and Sinomed. His investment portfolio also includes Ion Torrent Systems (acquired by Life Technologies for $725M), GenturaDx (acquired by Luminex), China Biologic Products (NASDAQ: CBPO), Epizyme (NASDAQ: EPZM), and Sunesis (NASDAQ: SNSS). Dr. Cui was also a co-founder of CNetwork, a San Francisco based non-profit organization dedicated to serving Chinese communities in North America. He received his PhD in Cancer Biology from Stanford University, and his BS in Molecular Biology from Peking University.

 

 

Min CuiMin Cui, Ph.D.
Managing Director
Dan ZabrowskiDan Zabrowski, Ph.D.
Venture Partner
Victor E. Tong, Jr.Victor E. Tong, Jr.
Partner
Ted DriscollTed Driscoll, Ph.D.
Partner
Qiang XuQiang Xu, Ph.D.
Principal
Nick PliamNick Pliam, M.D., Ph.D.
Principal

Tony TongTony Tong, Ph.D.
Vice President

Shasha DaiShasha Dai
Analyst
 
Copyright © 2011 Decheng Capital LLC. All Rights Reserved.